Inositol

myo-Inositol[1]
Names
IUPAC name
(1R,2R,3S,4S,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol
Other names
cis-1,2,3,5-trans-4,6-Cyclohexanehexol , Cyclohexanehexol,
Mouse antialopecia factor,
Nucite, Phaseomannite,
Phaseomannitol,
Rat antispectacled eye
factor, and Scyllite
(for the structural
isomer scyllo-Inositol)
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
KEGG
UNII
Properties
C6H12O6
Molar mass 180.16 g/mol
Density 1.752 g/cm3
Melting point 225 to 227 °C (437 to 441 °F; 498 to 500 K)
Pharmacology
A11HA07 (WHO)
Hazards
NFPA 704
Flammability code 0: Will not burn. E.g., water Health code 1: Exposure would cause irritation but only minor residual injury. E.g., turpentine Reactivity code 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g., liquid nitrogen Special hazards (white): no codeNFPA 704 four-colored diamond
0
1
0
Flash point 143 °C (289 °F; 416 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYN ?)
Infobox references

Inositol or cyclohexane-1,2,3,4,5,6-hexol is a chemical compound with formula C6H12O6 or (-CHOH-)6, a six-fold alcohol (polyol) of cyclohexane. It exists in nine possible stereoisomers, of which the most prominent form, widely occurring in nature, is cis-1,2,3,5-trans-4,6-cyclohexanehexol, or myo-inositol (former names meso-inositol or i-inositol).[2][3] Inositol is a sugar alcohol. Its taste has been assayed at half the sweetness of table sugar (sucrose).

myo-Inositol plays an important role as the structural basis for a number of secondary messengers in eukaryotic cells, the various inositol phosphates. In addition, inositol serves as an important component of the structural lipids phosphatidylinositol (PI) and its various phosphates, the phosphatidylinositol phosphate (PIP) lipids.

Inositol or its phosphates and associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.[4] In plants, the hexaphosphate of inositol, phytic acid or its salts, the phytates, are found. These serve as phosphate stores in the seed. Phytic acid occurs also in cereals with high bran content and also nuts and beans. Yet, inositol, when present as phytate, is not directly bioavailable to humans in the diet, since it is not digestible. Some food preparation techniques partly break down phytates to change this. Inositol as it occurs in certain plant-derived substances such as lecithins, however, is well-absorbed and relatively bioavailable.

myo-inositol (free of phosphate) was once considered a member of the vitamin B complex (formerly Vitamin B8); however, because it is produced by the human body from glucose, it is not an essential nutrient.[5]

Isomers and structure

The isomer myo-inositol is a meso compound possessing an optically inactive plane of symmetry through the molecule (meso-inositol is an obsolete name that refers to myo-inositol). Besides myo-inositol, the other naturally occurring stereoisomers (though in minimal quantities) are scyllo-, muco-, D-chiro-, and neo-inositol. The other possible isomers are L-chiro-, allo-, epi-, and cis-inositol. As their name denotes, the two chiro inositols are the only pair of inositol enantiomers, but they are enantiomers of each other, not of myo-inositol.

myo- scyllo- muco- chiro-
neo- allo- epi- cis-

In its most stable conformational geometry, the myo-inositol isomer assumes the chair conformation, which puts the maximum number of hydroxyls to the equatorial position, where they are farthest apart from each other. In this conformation, the natural myo isomer has a structure in which five of the six hydroxyls (the first, third, fourth, fifth, and sixth) are equatorial, whereas the second hydroxyl group is axial.[6]

Biosynthesis

myo-Inositol is synthesized from glucose-6-phosphate (G-6-P) in two steps. First, G-6-P is isomerised by an inositol-3-phosphate synthase enzyme (for example, ISYNA1) to myo-inositol 1-phosphate, which is then dephosphorylated by an inositol monophosphatase enzyme (for example, IMPA1) to give free myo-inositol. In humans, most inositol is synthesized in the kidneys, in typical amounts of a few grams per day.[7]

Function

Inositol and some of its mono- and polyphosphates function as the basis for a number of signaling and secondary messenger molecules. They are involved in a number of biological processes, including:

Phytic acid in plants

Phytic acid (IP6 or phytate), a derivative of inositol with six phosphate groups, is the principal storage form of phosphorus in many plant tissues, especially bran and seed.[14] Neither the inositol nor the phosphate in phytic acid in plants is available to humans, or to animals that are not ruminants, since it cannot be broken down, except by bacteria. Moreover, phytic acid also chelates important minerals such as calcium, magnesium, iron, and zinc, making them unabsorbable, and contributing to mineral deficiencies in people whose diets rely highly on bran and seeds for their mineral intake, such as occurs in developing countries.[15][16]

Inositol penta- (IP5), tetra- (IP4), and triphosphate (IP3) are also called "phytates".

Use in explosives manufacture

At the 1936 meeting of the American Chemical Society, professor Edward Bartow of the University of Iowa presented a commercially viable means of extracting large amounts of inositol from the phytic acid naturally present in waste corn. As a possible use for the chemical, he suggested 'inositol nitrate' as a more stable alternative to nitroglycerin.[17] Today, inositol nitrate is used to gelatinize nitrocellulose, thus can be found in many modern explosives and solid rocket propellants.[18]

Counter to road salt

When plants are exposed to increasing concentrations of road salt, the plant cells become dysfunctional and undergo apoptosis, leading to an inhibition of growth in plants. Inositol pretreatment could reverse the effects of salt on plants.[19][20]

Research and clinical applications

Large doses of inositol have been studied for treatment of depression: the evidence is insufficient to determine whether inositol treatment can reduce depression symptoms, but no evidence of harm or negative side effects is seen.[21]

Inositol is effective in reducing adverse neonatal outcomes in preterm babies who either have or are at a risk of developing respiratory distress syndrome (RDS).[22]

Inositol is considered a safe and effective treatment for PCOS. It works by increasing insulin sensitivity, which helps to improve ovarian function and reduce hyperandrogenism.[23] It is also shown to reduce risk of metabolic disease.[24]

Common use as a "cutting" agent

Inositol has been used as an adulterant (or cutting agent) in many illegal drugs, such as cocaine, methamphetamine, and sometimes heroin.[25] This use is presumed to be connected with one or more of the substance's properties of solubility, powdery texture, or reduced sweetness (50%) as compared with more common sugars.

Inositol is also used as a stand-in for cocaine in television shows and in film.[26]

Nutritional sources

myo-Inositol is naturally present in a variety of foods, although tables of this do not always distinguish between the bioavailable lecithin form, and the unavailable phytate form in grains.[27] According to research, foods containing the highest concentrations of myo-inositol (including its compounds) include fruits, beans, grains, and nuts.[27] Beans and grains, however, as seeds, contain large amounts of inositol as phytate. Some energy drinks also contain inositol.

See also

References

  1. Merck Index, 11th Edition, 4883.
  2. Synonyms in PubChem
  3. Synonyms in Commonchemistry.org
  4. Clements RS, Darnell B (1980). "Myo-inositol content of common foods: development of a high-myo-inositol diet". The American Journal of Clinical Nutrition. 33 (9): 1954–67. PMID 7416064.
  5. Reynolds, James E. F. (January 1, 1993). Martindale: The Extra Pharmacopoeia. 30. Pennsylvania: Rittenhouse Book Distributors. p. 1379. ISBN 0-85369-300-5. An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man
  6. S. M. N. Furse (2006). The Chemical and Bio-physical properties of Phosphatidylinositol phosphates (Thesis for M.Res.). Imperial College London.
  7. Parthasarathy LK, Seelan RS, Tobias C, Casanova MF, Parthasarathy RN (2006). "Mammalian inositol 3-phosphate synthase: its role in the biosynthesis of brain inositol and its clinical use as a psychoactive agent". Sub-cellular Biochemistry. 39: 293–314. PMID 17121280.
  8. Larner J (2002). "D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance". International Journal of Experimental Diabetes Research. 3 (1): 47–60. PMC 2478565Freely accessible. PMID 11900279. doi:10.1080/15604280212528.
  9. Gerasimenko JV, Flowerdew SE, Voronina SG, Sukhomlin TK, Tepikin AV, Petersen OH, Gerasimenko OV (2006). "Bile acids induce Ca2+ release from both the endoplasmic reticulum and acidic intracellular calcium stores through activation of inositol trisphosphate receptors and ryanodine receptors". The Journal of Biological Chemistry. 281 (52): 40154–63. PMID 17074764. doi:10.1074/jbc.M606402200.
  10. Kukuljan M, Vergara L, Stojilkovic SS (1997). "Modulation of the kinetics of inositol 1,4,5-trisphosphate-induced [Ca2+]i oscillations by calcium entry in pituitary gonadotrophs". Biophysical Journal. 72 (2 Pt 1): 698–707. Bibcode:1997BpJ....72..698K. PMC 1185595Freely accessible. PMID 9017197. doi:10.1016/S0006-3495(97)78706-X.
  11. Rapiejko PJ, Northup JK, Evans T, Brown JE, Malbon CC (1986). "G-proteins of fat-cells. Role in hormonal regulation of intracellular inositol 1,4,5-trisphosphate". The Biochemical Journal. 240 (1): 35–40. PMC 1147372Freely accessible. PMID 3103610.
  12. Shen X, Xiao H, Ranallo R, Wu WH, Wu C (2003). "Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates". Science. 299 (5603): 112–4. PMID 12434013. doi:10.1126/science.1078068.
  13. Steger DJ, Haswell ES, Miller AL, Wente SR, O'Shea EK (2003). "Regulation of chromatin remodeling by inositol polyphosphates". Science. 299 (5603): 114–6. PMC 1458531Freely accessible. PMID 12434012. doi:10.1126/science.1078062.
  14. Phytic acid
  15. Hurrell RF (2003). "Influence of vegetable protein sources on trace element and mineral bioavailability". The Journal of Nutrition. 133 (9): 2973S–7S. PMID 12949395.
  16. Committee on Food Protection; Food and Nutrition Board; National Research Council (1973). "Phytates". Toxicants Occurring Naturally in Foods. National Academy of Sciences. pp. 363–371. ISBN 978-0-309-02117-3.
  17. Laurence, William L. "Corn by-product yields explosive", The New York Times. April 17, 1936. Page 7.
  18. Ledgard, Jared. The Preparatory Manual of Explosives, 2007. p. 366.
  19. Chatterjee J, Majumder AL (2010). "Salt-induced abnormalities on root tip mitotic cells of Allium cepa: prevention by inositol pretreatment". Protoplasma. 245 (1-4): 165–72. PMID 20559853. doi:10.1007/s00709-010-0170-4.
  20. Theerakulp, P.; Gunnula, W. (2012). "Exogenous Sorbitol and Trehalose Mitigated Salt Stress Damage in Salt-sensitive but not Salt-tolerant Rice Seedlings". Asian Journal of Crop Science. 4 (4): 165–70. doi:10.3923/ajcs.2012.165.170.
  21. Taylor MJ, Wilder H, Bhagwagar Z, Geddes J (2004). "Inositol for depressive disorders". The Cochrane Database of Systematic Reviews (2): CD004049. PMID 15106232. doi:10.1002/14651858.CD004049.pub2.
  22. Howlett A, Ohlsson A, Plakkal N (2015). "Inositol in preterm infants at risk for or having respiratory distress syndrome". The Cochrane Database of Systematic Reviews (2): CD000366. PMID 25927089. doi:10.1002/14651858.CD000366.pub3.
  23. Monastra G, Unfer V, Harrath AH, Bizzarri M (2017). "Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients". Gynecological Endocrinology. 33 (1): 1–9. PMID 27898267. doi:10.1080/09513590.2016.1247797.
  24. Nordio M, Proietti E (2012). "The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone". European Review for Medical and Pharmacological Sciences. 16 (5): 575–81. PMID 22774396.
  25. http://feedadditivechina.com/6-16-inositol.html%5B%5D
  26. Golianopoulos, Thomas. "Drug Doubles: What Actors Actually Toke, Smoke and Snort on Camera". Wired Magazine. Retrieved 14 May 2012.
  27. 1 2 Clements RS, Darnell B (1980). "Myo-inositol content of common foods: development of a high-myo-inositol diet". The American Journal of Clinical Nutrition. 33 (9): 1954–67. PMID 7416064.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.